Ngā hua rapu - R. Verrijk

  • E whakaatu ana i te 1 - 2 hua o te 2
Whakamahine hua
  1. 1
    Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application

    Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application mā Marja J. Nell, G. Sandra Tjabringa, Amon R. Wafelman, R. Verrijk, Pieter S. Hiemstra, Jan W. Drijfhout, J. J. Grote

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Single ocular injection of a sustained-release anti -VEGF delivers 6 months pharmacokinetics and efficacy in a primate laser CNV model

    Single ocular injection of a sustained-release anti -VEGF delivers 6 months pharmacokinetics and efficacy in a primate laser CNV model mā Peter Adamson, Thomas Wilde, Eric Dobrzynski, Caroline Sychterz, Rodd Polsky, Edit Kurali, Richard Haworth, Chi-Man Tang, Justyna Korczyńska, Fiona Cook, Irene Papanicolaou, Lemy Tsikna, Chris Roberts, Zoe Hughes-Thomas, James Walford, D.F.C. Gibson, John Warrack, Jos Smal, R. Verrijk, Paul E. Miller, T. Michael Nork, Jeffery J. Prusakiewicz, Timothy Streit, Steven D. Sorden, Craig B Struble, Brian J. Christian, I. Catchpole

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: